Scientists from Piramal led the first exploration by an Indian pharmaceutical company to develop drug leads from geographies like Antarctica.
A joint venture agreement was entered into with Sateliec, France for dental care products.
Gujarat Glass is merged with the group company, Nicholas Piramal India Ltd.
Acquired Gujarat Glass.
Nicholas forges alliance with scientists from Imperial College of the UK to carry out research in the field of rheumatoid arthritis.
ICI Pharma is acquired.
Piramal Glass acquires Ceylon Company Ltd, Sri Lanka.
NPIL entered into an agreement with Reckitt & Colman for joint marketing of the latter's OTC products in India.
The bulk drug division of Sumitra Pharmaceutical and Chemicals Ltd. Hyderabad transferred to NPIL.
Piramal entered into a joint venture agreement with Allergan of U.S.A., the leading manufacturers of Ophthalmic products.
Acquired Nicholas Laboratories.
In the early 1980s, a young Ajay Piramal takes over the reins of the Piramal Group.